Skip To Content

Uveitis

Fork in the Road
Announcing the FBC’s Vision Care Pathways

Along with the brain, the eye is one of the human body’s most intricate components, an elaborate collection of parts working in tandem to do one thing: gather external light and focus…

Read More
Cayouette Lab Tour
$3.09 million in funding for blinding eye diseases is “a real success story for FBC”

When Dr. Michel Cayouette learned the astounding news that he had been awarded $3.09 million from the Canadian Institutes of Health Research (CIHR) to support his research into blinding eye diseases for…

Read More
DNA
RNA Therapies for Inherited Retinal Diseases (IRDs)

I recently participated in a tremendously inspiring meeting, hosted by ProQR, which is a company that is creating new treatments for people living with rare diseases, including blinding eye diseases. ProQR specializes…

Read More
Gene Therapy
Four Vision Research and Treatment Trends to Watch in 2018   

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…

Read More
Cell Illustration
World’s First Experimental Therapy Involving Reprogrammed Donor Stem Cells Aims to Treat Macular Degeneration

Stem cells are frequently in the news. At Fighting Blindness Canada (FBC) we love reading about stem cell discoveries, but high-frequency reporting can make it challenging to identify truly significant breakthroughs, such…

Read More
Dr. Philippe Monnier
Halting Cell Death to Save Vision

It is a fundamental principle in biology: eventually, everything dies. Dr. Philippe Monnier is no stranger to the principle. He confronts it within his lab on a regular basis. But while he…

Read More

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.

I have read and accepted the privacy policy